Browse by all authors Browse By Author Name - McCaughan,+G.+W.

Browse Results (15 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Haber, P. S., Keogh, G. W., Apte, M. V., Moran, C. S., Stewart, N. L., Crawford, D. H. G., Pirola, R. C., McCaughan, G. W., Ramm, G. A. and Wilson, J. S. (1999) Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. American Journal of Pathology, 155 4: 1087-1095. doi:10.1016/S0002-9440(10)65211-X 106   226 0
McCaughan, G.W. and Lynch, S. V. (2001) Adult living donor liver transplantation: Another Pandora's box?. The Medical Journal of Australia, 175 4: 202-204. 55  
McCaughan, G. W., Roberts, S. K., Weltman, M., Crawford, D. H., Sievert, W., Cheng, W., Rawlinson, W., Yoshihara, M., McCloud, P. I., Rizkalla, B. and Dore, G. J. (2009). Advanced fibrosis in genotype 1 HCV infected patients receiving antiviral therapy is associated with virologic relapse independent of rapid (RVR) and early (EVR) virologic response. In: The 60th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2009. 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, U.S.A., (1027A-1028A). 30 October - 3 November 2009. doi:10.1002/hep.23307 49   0 0
McCaughan, G. W. and Macdonald, G. A. (1999) Cirrhosis and liver cancer. Australian Family Physician, 28 Special Issue: SI46-SI50. 53  
Angus, P. W., McCaughan, G. W., Gane, E. J., Crawford, D. H. G. and Harley, H. (2000) Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. Liver Transplantation, 6 4: 429-433. doi:10.1053/jlts.2000.8310 27   162 Cited 214 times in Scopus214 0
Angus, P.W., Gane, E.J., Crawford, D.H. and McCaughan, G.W. (1999). Combination low dose hepatitis B immune globulin (HBIG) and lamivudine therapy provides effective prophylaxis against post transplant hepatitis B. In: Abstracts of the 50th Annual Meeting of the American Association for the Study of Liver Disease. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, (301A-301A). 5-9 November 1999. 29   3
Wang, M., Gorrell, M. D., McCaughan, G. W. and Dickinson, R. G. (1999). Dipeptidyl peptidase IV is a target for covalent adduct formation with the acyl glucuronide metabolite of the anti-inflammatory drug Zomepirac. In: Abstracts of the Scientific Meeting of ASCEPT. 33rd Annual Scientific Meeting of ASCEPT, Sydney Convention & Exhibition Cen., Darling Harbour, (137-137). 4 - 8 Dec, 1999. 36  
Wang, M., Gorrell, M. D., McCaughan, G. W. and Dickinson, R. G. (2001) Dipeptidyl peptidase IV is a target for covalent adduct formation with the acyl glucuronide metabolite of the anti-inflammatory drug zomepirac. Life Sciences, 68 7: 785-797. doi:10.1016/S0024-3205(00)00981-4 51   23 Cited 26 times in Scopus26 0
Powell, L. W., Selby, W. S., McCaughan, G. W. and Grimm, M. C. (1999) Fifty years of gastroenterology in Australia. Journal of Gastroenterology and Hepatology, 14 2: 179-193. doi:10.1046/j.1440-1746.1999.01825.x 18   0
Latt, N. C., Spencer, J. D., Beeby, P., McCaughan, G. W., Saunders, J. B., Collins, E. and Cossart, Y. E. (2000) Hepatitis C virus infection: Hepatitis C in injecting drug-using women during and after pregnancy. Journal of Gastroenterology and Hepatology, 15 2: 175-181. doi:10.1046/j.1440-1746.2000.02060.x 84   17 Cited 19 times in Scopus19 0
Kitson, M. T., Dore, G. J., George, J., Button, P., McCaughan, G. W., Crawford, D. H., Sievert, W., Weltman, M. D., Cheng, W. S. and Roberts, S. K. (2013). Interleukin-28B rs12979860 C allele is protective against advanced fibrosis in chronic he[atotos C genotype 1 infection: analysis of the Australasian Chariot Study Cohort. In: Abstracts of The International Liver Congress™ 2013 – 48th Annual meeting of the European Association for the Study of the Liver. International Liver Congress / 48th Annual Meeting of the European Association for the Study of the Liver (EASL), Amsterdam Netherlands, (S191-S191). 24-28 April 2013. 26   0
Gane, E. J., Angus, P. W., Strasser, S., Crawford, D. H. G., Ring, J., Jeffrey, G. P. and McCaughan, G. W. (2007) Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplant. Gastroenterology, 132 3: 931-937. doi:10.1053/jgastro.2007.01.005 75   128 Cited 170 times in Scopus170 0
Thomson, R.K., Koorey, D.J., Angus, P.W., Crawford, D.H. and McCaughan, G.W. (2000). Lamivudine therapy for chronic hepatitis B patients receiving immunosuppression for non-hepatic diseases. In: Abstracts of the Annual Meeting of the British Society of Gastroenterology. Annual Meeting of the British Society of Gastroenterology, Unknown, (A59-A59). 2000. 31   0
Thomson, R.K., Koorey, D.J., Angus, P.W., Crawford, D.H. and McCaughan, G.W. (1999). Lamivudine therapy for patients with chronic hepatitis B receiving immunosuppression for non-hepatic diseases. In: Abstracts of the 50th Annual Meeting of the American Association for the Study of Liver Disease. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, (643A-643A). 5-9 November 1999. 31   0
Roberts, S. K., Ferenci, P., Yoshihara, M., Crawford, D. H., Sieverf, W., McCaughan, G. W., Cheng, W., Weltman, M., Rawlinson, W. D., McCloud, P. I., Rizkalla, B. and Dore, G. J. (2010). Non-Svr to peginterferon Alfa-2a therapy and ribavirin is strongly predicted by baseline factors and week 8 on-treatment viral load in Hcv genotype (gt) 1 patients: New insights from cart analysis of the chariot study. In: Hepatology. 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, United States, (801A-802A). 29 Oct-2 Nov, 2010. 49   0